Turkey’s Talent Hope
With its current turbulent economic and political climate, Turkey is betting its future prosperity on 2 key aspects – its young talent pool and its location as an intersection between…
Address: ‘Eski Büyükdere Cad. Dilaver Sok. NO:4 34418
Oto Sanayi 4 Levent / İstanbul
,Turkey
Tel: +90 212 316 78 00
Web: http://www.aliraif.com.tr/
Ali Raif was founded under the name of Ali Raif ve Şeriki (Ali Raif and Associate) in 1928. Then company was reorganized in order to trade in pharmaceuticals industry by Muzaffer Turhan in 1963. Since 1983, the company has had operations under the name of Ali Raif Pharmaceutical Inc. Co.
Ali Raif was marketing pharmaceuticals as a licensee of multinational companies in the early years of its foundation. Then the company became one of the leading companies of the Turkish Pharmaceutical Industry starting to import finished pharmaceuticals and to produce and market generic pharmaceuticals.
After Ali Raif commenced generic pharmaceuticals licensing, producing and marketing, export opportunities started to arise in parallel to them. Export activities started with Azerbaijan and Georgia has enlarged with EU countries in 2003. Since 2005 they have speeded up greatly.
The countries that have been export are England, Portugal, Hungary, Azerbaijan, Georgia, The Philippines, Bulgaria, Spain, Algeria, and Poland.
Ali Raif has nearly 150 pharmaceuticals with their forms in therapeutic fields such as cardiovascular, diabetics, gastrointestinal, analgesic, anti-inflammatory, anti-flu, antihistaminic, central nervous system.
Headquarters and production facilities are located in İkitelli, İstanbul, has totally 10 regional offices in Turkey.
With its current turbulent economic and political climate, Turkey is betting its future prosperity on 2 key aspects – its young talent pool and its location as an intersection between…
Ersin Erfa, general manager of Centurion, which recently set up one of Turkey’s largest biotechnology plants in Ankara, dives into the world of double-digit growth and a booming export business,…
Prof. Dr. Sabahattin Aydın, Rector of Medipol University, chairman of the Executive Council of TUSAP Healthcare Platform, former executive board member of the World Health Organization (WHO), former deputy undersecretary…
Fikret Baltaoglu of Laboratoires Expanscience, reveals all on the company’s recent expansion into the Turkish market after acquiring its distribution partner. He also sheds light on how the Turkish healthcare…
Hasan Ulusoy, chairman of Nobel Ilac, elaborates on his company’s tremendous successes in Turkey and how they have differentiated themselves through early investment in biotechnology and firmly grasping international opportunities.…
Hakan Yurdakul, Head of Economy Monitoring and Coordination at the Presidency Office of the Republic of Turkey, elaborates on the strategic importance of the pharmaceutical and healthcare industries for the…
Prof. Dr. Temel Yilmaz, president of the Turkish Diabetes Foundation, discussed how the disease has made a massive impact in country and what can be done to tackle the issue…
Two months into the role, Umut Meriç, general manager for Chiesi Turkey, discusses the affiliate’s rapid progression and his plans to ensure Turkish patients benefit from the global company’s latest…
From collaborating with authorities to tackling awareness surrounding mental illnesses, Altan Gorseval, country manager of Lundbeck Turkey, paints an accurate picture of the company’s dedication to improving mental health and…
Turkey has one of the most revered Social Security Systems in the world, providing its citizens with free healthcare and access to a long list of innovative cancer drugs. However, with one…
Dr. Hakkı Gürsöz, president of the Turkish Medicines and Medical Devices Agency (TiTCK), provides insights into recent localization and pricing policies and delivers strong messages to both domestic and foreign…
Dr. Erdal Bozdoğan, the recently appointed general manager of Takeda Turkey, leverages his 20 years of experience in the pharmaceutical industry and his expertise of emerging markets to document Turkey’s…
See our Cookie Privacy Policy Here